Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17046465 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Placebo;   Drug: SU011248
2 Active, not recruiting Rechallenge of Imatinib in GIST Having no Effective Treatment
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Imatinib;   Drug: Placebo

Indicates status has not been verified in more than two years